Correlation of hsa-mirna-342–3p and SOX 6 Expression with Diabetic Nephropathy Classification, Prognostic Histomorphological Parameters and Laboratory Findings in Diabetic Nephropathy
Gözde Arslan , Yasemin Yuyucu Karabulut , İrem Yeleser , Mehmet Emin Erdal , Serap Demir , Asena Ayça Özdemir
{"title":"Correlation of hsa-mirna-342–3p and SOX 6 Expression with Diabetic Nephropathy Classification, Prognostic Histomorphological Parameters and Laboratory Findings in Diabetic Nephropathy","authors":"Gözde Arslan , Yasemin Yuyucu Karabulut , İrem Yeleser , Mehmet Emin Erdal , Serap Demir , Asena Ayça Özdemir","doi":"10.1016/j.anndiagpath.2025.152461","DOIUrl":null,"url":null,"abstract":"<div><div>Diabetic nephropathy (DN) is one of the leading causes of end-stage renal disease. The most popular biomarkers in current research on DN are microRNAs. There are studies showing that while the expression of SOX6 increases, hsa-miR-342–3p expression decreases in kidney tissues with DN. The current study evaluated hsa-miR-342–3p expression by Real Time PCR and SOX6 expression by immunohistochemistry in a cohort of 110 DN biopsies, as well as their relationship with various clinical and histomorphological parameters. An inverse relationship between expression of hsa-miR-342–3p and SOX6 was demonstrated. SOX6 genetic expression was correlated with serum creatinine and tubular basement membrane thickening. Immunohistochemically, SOX6 staining was observed in mesangial cells and podocytes in 21 patients, with tubular staining in 45, and interstitial staining in 27 patients. Tubular staining was associated with proteinuria, interstitial fibrosis and inflammation; interstitial staining was associated with creatinine; and staining in the glomerular compartment was associated with advanced DN class. Our study is the first in the literature in which SOX6 was applied immunohistochemically in human kidney tissue, and its relation with DN classes was examined. We demonstrate its correlation with laboratory and histomorphological parameters, and provide a rational basis for future studies on larger patient groups that may result in the development of new biomarkers to predict the progression of DN and enhance its treatment.</div></div>","PeriodicalId":50768,"journal":{"name":"Annals of Diagnostic Pathology","volume":"76 ","pages":"Article 152461"},"PeriodicalIF":1.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Diagnostic Pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1092913425000267","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic nephropathy (DN) is one of the leading causes of end-stage renal disease. The most popular biomarkers in current research on DN are microRNAs. There are studies showing that while the expression of SOX6 increases, hsa-miR-342–3p expression decreases in kidney tissues with DN. The current study evaluated hsa-miR-342–3p expression by Real Time PCR and SOX6 expression by immunohistochemistry in a cohort of 110 DN biopsies, as well as their relationship with various clinical and histomorphological parameters. An inverse relationship between expression of hsa-miR-342–3p and SOX6 was demonstrated. SOX6 genetic expression was correlated with serum creatinine and tubular basement membrane thickening. Immunohistochemically, SOX6 staining was observed in mesangial cells and podocytes in 21 patients, with tubular staining in 45, and interstitial staining in 27 patients. Tubular staining was associated with proteinuria, interstitial fibrosis and inflammation; interstitial staining was associated with creatinine; and staining in the glomerular compartment was associated with advanced DN class. Our study is the first in the literature in which SOX6 was applied immunohistochemically in human kidney tissue, and its relation with DN classes was examined. We demonstrate its correlation with laboratory and histomorphological parameters, and provide a rational basis for future studies on larger patient groups that may result in the development of new biomarkers to predict the progression of DN and enhance its treatment.
糖尿病肾病(DN)是终末期肾脏疾病的主要原因之一。目前研究DN最流行的生物标志物是microrna。有研究表明,在DN肾组织中,SOX6表达升高,hsa-miR-342-3p表达降低。本研究通过Real Time PCR评估了110例DN活检中hsa-miR-342-3p的表达,通过免疫组织化学评估了SOX6的表达,以及它们与各种临床和组织形态学参数的关系。hsa-miR-342-3p与SOX6的表达呈负相关。SOX6基因表达与血清肌酐和肾小管基底膜增厚相关。免疫组化结果显示,21例患者系膜细胞和足细胞被SOX6染色,45例患者系膜细胞被SOX6染色,27例患者系膜细胞被SOX6染色。小管染色与蛋白尿、间质纤维化和炎症有关;间质染色与肌酐有关;肾小球间室染色与晚期DN相关。我们的研究是文献中首次将SOX6免疫组织化学应用于人肾组织,并研究其与DN类型的关系。我们证明了其与实验室和组织形态学参数的相关性,并为未来在更大的患者群体中进行研究提供了合理的基础,这些研究可能会导致开发新的生物标志物来预测DN的进展并加强其治疗。
期刊介绍:
A peer-reviewed journal devoted to the publication of articles dealing with traditional morphologic studies using standard diagnostic techniques and stressing clinicopathological correlations and scientific observation of relevance to the daily practice of pathology. Special features include pathologic-radiologic correlations and pathologic-cytologic correlations.